Trademark applications and grants for Maxia Pharmaceuticals Inc. Maxia Pharmaceuticals Inc has 3 trademark applications. The latest application filed is for "MAXIA PHARMACEUTICALS, INC."
Patent Application | Date |
---|---|
Thiazolidinedione derivatives for the treatment of diabetes and other diseases 20030153606 - 10/334932 Pfahl, Magnus ;   et al. | 2003-08-14 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"MAXIA PHARMACEUTICALS, INC." 78154718 |
MAXIA PHARMACEUTICALS, INC. 2002-08-15 |
"GENOMIC MODULATOR" 76194440 |
GENOMIC MODULATOR 2001-01-16 |
"MAXIA" 75509424 |
MAXIA 1998-06-26 |
SEC | 0001050942 | MAXIA PHARMACEUTICALS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.